OB review questions Flashcards
(89 cards)
643–Which of the following drugs does NOT pass the placenta easily?
A. Etomidate
B. Ephedrine
C. Atropine
D. Glycopyrrolate
D) glycopyrrolate
The fetal/maternal (F/M) drug ratio is a way to quantitatively describe drug transfer across the placenta. Time is also important when considering how much drug crosses into the fetus. Many anesthetic drugs cross the placenta such as local anesthetics, intravenous induction agents (e.g., propofol [F/M ratio of 0.7- 1.1], etomidate [F/M ratio of 0.5], ketamine [F/M ratio of 0.5]), inhalation agents (e.g., volatile anesthetics and nitrous oxide [F/M ratio of 0.7]), and narcotics (e.g., fentanyl [F/M ratio of 0.4], remifentanil [F/M ratio of 0.9], morphine [F/M ratio of 0.6]) and with time may affect the fetus/newborn. For vasopressors, ephedrine has an F/M ratio of 0.7, whereas phenylephrine has an F/M ratio of 0.2. The ionized neuromuscular blocking agents do not readily cross the placenta (F/M ratios of non-depolarizing drugs are around 0.1-0.2); succinylcholine, a depolarizing muscle relaxant, crosses very poorly as well. The anticholinergic drugs atropine and scopolamine have F/M drug ratios of 1.0 and readily cross the placenta, whereas glycopyrrolate has an F/M drug ratio of 0.1 and poorly crosses the placenta. Because the anticholinesterase agents (neostigmine, pyridostigmine, and edrophonium) cross the placenta to a limited extent but more so than glycopyrrolate, a pregnant patient undergoing nonobstetric surgery in which neuromuscular blocking drugs are being reversed with anticholinesterase agents should have atropine rather than glycopyrrolate used with the anticholinesterase mixture to prevent possible fetal bradycardia (Chestnut: Chestnut’s Obstetric Anesthesia, ed 5, pp 63–69; Suresh: Shnider and Levinson’s Anesthesia for Obstetrics, ed 5, pp 47–51).
- What is the P50 of fetal hemoglobin at term?
A. 12
B. 18
C. 24
D. 30
(B) Newborns have high hemoglobin levels around 15 to 20 g/100 mL. The term P50 denotes the blood oxygen tension (Pao2) that produces 50% saturation of erythrocyte hemoglobin. The P50 value of fetal hemoglobin is 18 mm Hg versus the adult value of 27 mm Hg. Thus, fetal hemoglobin has a higher affinity for oxygen than maternal hemoglobin (Chestnut: Chestnut’s Obstetric Anesthesia, ed 5, pp 83–84; Suresh: Shnider and Levinson’s Anesthesia for Obstetrics, ed 5, pp 26–27).
653–Cardiac output increases dramatically during pregnancy and delivery. The cardiac output returns to nonpregnant values by how long postpartum?
A. 12 hours
B.1day
C. 2 weeks
D. 6 months
(C) 2 weeks
The numerous changes that take place in the cardiovascular system during pregnancy provide for the needs of the fetus and prepare the mother for labor and delivery. During the first trimester of pregnancy, cardiac output increases by approximately 30% to 40%. At term, the cardiac output is increased 50% over nonpregnant values. This increase in cardiac output is due to an increase in stroke volume and an increase in heart rate. During labor, the cardiac output increases another 10% to 15% during the latent phase, 25% to 30% during the active phase, and 40% to 45% during the expulsive stage. Each uterine contraction increases the cardiac output by about 10% to 25%. The greatest increase in cardiac output occurs immediately after delivery of the newborn, when the cardiac output can increase to 75% above prelabor values. This final increase in cardiac output is attributed primarily to autotransfusion and increased venous return associated with uterine involution. Cardiac output falls to prelabor values within 2 days after delivery; however, it takes about 2 weeks for the cardiac output to decrease to non- pregnant values (Chestnut: Chestnut’s Obstetric Anesthesia, ed 5, pp 16–18; Suresh: Shnider and Levinson’s Anesthesia for Obstetrics, ed 5, pp 1–2).
655–Uterine blood flow at term pregnancy typically increases to about
A. 100 mL/min
B. 250 mL/min
C. 500 mL/min
D. 750 mL/min
(D) 750
Uterine blood flow increases dramatically from 50 to 100 mL/min before pregnancy to about 700 to 900 mL/min at term (i.e., >1 unit of blood per minute). From 70% to 90% of the uterine blood flow at term goes to the intervillous spaces. Uterine blood flow is related to the perfusion pressure (uterine arterial pressure minus uterine venous pressure) divided by the uterine vascular resistance. Thus, factors that decrease uterine blood flow include systemic hypotension, aortocaval compression, uterine contraction, and vasoconstriction (Chestnut: Chestnut’s Obstetric Anesthesia, ed 5, pp 40–42; Suresh: Shnider and Levinson’s Anesthesia for Obstetrics, ed 5, pp 23–24).
656
657–Which of the following cardiovascular parameters is decreased at term?
A. Central venous pressure
B. Pulmonary capillary wedge pressure
C. Systemic vascular resistance
D. Left ventricular end-systolic volume
(C) There is no change in central venous pressure, pulmonary capillary wedge pressure, pulmonary artery diastolic pressure, or left ventricular end-systolic volume. Left ventricular end-diastolic volume is increased, as is stroke volume, ejection fraction, heart rate, and cardiac output. Systemic vascular resistance is decreased about 20% (Chestnut: Chestnut’s Obstetric Anesthesia, ed 5, pp 16–19; Suresh: Shnider and Levinson’s Anesthesia for Obstetrics, ed 5, pp 1–3).
- Which of the following drugs does NOT pass the placenta easily?
A. Etomidate
B. Ephedrine
C. Atropine
D. Glycopyrrolate
(D)The fetal/maternal (F/M) drug ratio is a way to quantitatively describe drug transfer across the placenta. Time is also important when considering how much drug crosses into the fetus. Many anesthetic drugs cross the placenta, such as local anesthetics, IV induction agents (e.g., propofol [F/M ratio of 0.7-1.1], etomidate [F/M ratio of 0.5], ketamine [F/M ratio of 0.5]), inhalation agents (e.g., volatile anesthetics and nitrous oxide [F/M ratio of 0.7]), and narcotics (e.g., fentanyl [F/M ratio of 0.4], remifentanil [F/M ratio of 0.9], morphine [F/M ratio of 0.6]) and with time may affect the fetus/newborn. For vasopressors, ephedrine has an F/M ratio of 0.7, whereas phenylephrine has an F/M ratio of 0.2. The ionized neuromuscular blocking agents do not readily cross the placenta (F/M ratios of nondepolarizing drugs are around 0.1-0.2); succinylcholine, a depolarizing muscle relaxant, crosses very poorly as well. The anticholinergic drugs atropine and scopolamine have F/M drug ratios of 1.0 and readily cross the placenta, whereas glycopyrrolate has an F/M drug ratio of 0.1 and poorly crosses the placenta. Because the anticholinesterase agents (neostigmine, pyridostigmine, and edrophonium) cross the placenta to a limited extent but more so than glycopyrrolate, a pregnant patient undergoing nonobstetric surgery in which neuromuscular blocking drugs are being reversed with anticholinesterase agents should have atropine rather than glycopyrrolate used with the anticholinesterase mixture to prevent possible fetal bradycardia
- A 38-year-old obese patient is receiving subcutaneous low-molecular-weight heparin (LMWH) for thromboprophylaxis. Her epidural for an elective cesarean delivery was placed 14 hours after the heparin was stopped. She developed Horner syndrome on the left side 30 minutes after placement of the epidural. On physical examination, a T4 anesthetic level is noted, but aside from the Horner syndrome no other findings are revealed. The most appropriate course of action at this time would be to
A. Remove the epidural
B. Consult a neurosurgeon
C. Obtain a computed tomographic scan
D. None of the above
(D)LMWHs are used for both prophylaxis and treatment of arterial and venous thromboembolism. The elimination half-life of LMWH is 3 to 6 hours after subcutaneous injection in patients with normal renal function. With severe renal insufficiency, the half-life of LMWH can be up to 16 hours. At least 12 hours should elapse before performing any neuraxial techniques (e.g., placement or removal of an epidural catheter) to decrease the likelihood of a spinal hematoma forming after low-dose prophylaxis with LMWH (e.g., enoxaparin 30mg BID or 40mg once daily). If high-dose LMWH is used for therapeutic anticoagulation (e.g., enoxaparin 1mg/kg BID or 1.5mg/kg once daily), you should wait at least 24 hours to decrease the likelihood of a spinal hematoma forming. A postprocedure dose of enoxaparin should usually be given no sooner than 4 hours after epidural catheter is removed. In all cases, the benefit-risk of thrombosis and bleeding should be made. If the patient has back pain and unexpected neurologic paralysis, a workup for an epidural hematoma should be performed. This case demonstrates a benign condition in which the sympathetic nerve supply to the eye is blocked (Horner syndrome [triad of miosis, ptosis, and anhidrosis]). This occasionally develops after a lumbar epidural anesthetic, even when the highest dermatome level blocked is below T5. It may be related to the superficial anatomic location of the descending spinal sympathetic fibers that lie just below the spinal pia of the dorsolateral funiculus (which is within diffusion range of subanesthetic concentrations of local anesthetics in the cerebrospinal fluid) as well as increased sensitivity to local anesthetics during pregnancy
- What percentage of all pregnancies is affected by hypertension?
A. 3%-5%
B. 7%-10%
C. 15%
D. 20%
(B)Hypertension is defined as a systolic blood pressure (SBP) ≧140mm Hg or diastolic blood pressure (DBP) ≧90mm Hg on two occasions at least 4 hours apart, while the patient is at bed rest (unless antihypertensive therapy has been started); it occurs in 7% to 10% of all pregnancies worldwide. If the SBP is ≧160mm Hg or the DBP is ≧110mm Hg, the two readings can be done within a few minutes and antihypertensive medications can be started. Hypertension is a leading cause of maternal death worldwide. Hypertension during pregnancy is divided into four groups: preeclampsia-eclampsia, chronic hypertension (of any cause), chronic hypertension with superimposed preeclampsia, and gestational hypertension.
- A 16-year-old, anxious, preeclamptic patient in active labor develops back pain after the placement of an epidural for labor analgesia. The pain is severe, and the patient has more weakness of the legs than expected. The most appropriate course of action at this time would be to
A. Inject a higher concentration of a local anesthetic or add intravenous (IV) narcotics
B. Replace the epidural and use epidural narcotics to decrease the motor weakness
C. Reassure her that she will get better with delivery
D. Consult a neurosurgeon
(D)Epidural hematomas and epidural abscesses are quite rare. Severe back pain and/or leg weakness that is greater than expected (or the recurrence of weakness after partial recovery of a neuraxial block) are presenting symptoms of spinal cord compression. Epidural hematomas can develop within 12 hours of a neuraxial procedure, whereas epidural abscesses usually take days to develop and also present with fever and leukocytosis. These conditions need imaging (e.g., magnetic resonance imaging [MRI]) and neurosurgical consultation. Studies have shown that when spinal cord decompression occurs within 8 hours of the onset of paralysis, neurologic recovery is significantly better than after 8 hours. Although epidural hematoma formation is rare, clotting disorders and perhaps marked difficulty in placing a block could lead to epidural bleeding and hematoma formation. Because the preeclamptic patient may develop a coagulopathy, one should carefully evaluate her coagulation status before initiating a regional block. Most anesthesiologists would evaluate a platelet count in the preeclamptic patient and look for any clinical signs of unexplained bleeding before initiating a regional block. Because an epidural blood patch often is performed with 20mL of blood, the epidural hematoma that causes spinal cord compression is probably significantly greater
- Magnesium sulfate (MgSO4) is used as an anticonvulsant in patients with preeclampsia and for fetal neuroprotection and sometimes for short-term tocolysis. MgSO4 may produce any of the following effects EXCEPT
A. Sedation
B. Respiratory paralysis
C. Inhibition of acetylcholine (ACh) release at the myoneural junction
D. Hypertension when used with nifedipine
(D)The normal serum magnesium level is 1.5 to 2mEq/L, with a therapeutic range of 4 to 8mEq/L. Note: many laboratories report values in mg/dL (1mEq/L = 1.2mg/dL). As magnesium sulfate is administered IV, patients often note a warm feeling in the vein as well as some sedation. With increasing serum levels, loss of deep tendon reflexes occurs at 10mEq/L (12mg/dL), respiratory paralysis occurs at 15mEq/L (18mg/dL), and cardiac arrest at greater than 25mEq/L (>30mg/dL) can occur. Magnesium decreases the release of ACh at the myoneural junction and decreases the sensitivity of the motor endplate to ACh. This can produce marked potentiation of nondepolarizing muscle relaxants. The effect on depolarizing muscle relaxants is less clear, and most clinicians use standard intubating doses of succinylcholine (i.e., 1-1.5mg/kg) followed by a markedly reduced dose of a nondepolarizing relaxant if needed. Because magnesium antagonizes the effects of α-adrenergic agonists, ephedrine is usually preferred over phenylephrine if a vasopressor is needed to restore blood pressure, along with fluids, after a neuraxial blockade. When a calcium channel blocker, such as nifedipine, is administered along with magnesium, greater hypotension has resulted. The antidote for magnesium toxicity is calcium (which, if needed, should be administered slowly)
- Normal fetal heart rate (FHR) is
A. 60 to 100 beats/min
B. 90 to 130 beats/min
C. 110 to 160 beats/min
D. 150 to 200 beats/min
(C)Fetal monitors consist of a two-channel recorder for simultaneous recording of FHR and uterine activity. In looking at the FHR, one assesses the baseline rate, the FHR variability, and the periodic changes (accelerations or decelerations) that occur with uterine contractions. The normal FHR varies between 110 and 160beats/min. See also Answer 703
- Which of the following is the MOST likely cause of pregnancy-related deaths in the United States (2011-2013)?
A. Anesthesia complications
B. Hemorrhage
C. Cardiovascular disease
D. Hypertensive disorders of pregnancy
(C)Worldwide, hemorrhage (H), infection (I), and hypertensive disorders of pregnancy (preeclampsia [P]), or HIP, account for more than half of all maternal deaths. In the developed world, hypertensive disorders, infection, and hemorrhage account for about one third of maternal deaths. The rate of pregnancy-related mortality in the United States has been increasing from 7.2 deaths per 100,000 live births in 1987, to 14.5 deaths per 100,000 live births in 2000, to 17.3 deaths per 100,000 live births in 2013. The reason for the increase in deaths is unclear but may be related to more pregnant women having chronic health conditions such as hypertension, diabetes, obesity, and heart disease. The causes of pregnancy-related deaths in the United States for the years 2011 to 2013 were cardiovascular disease (15.5%), noncardiovascular disease (14.5%), infection or sepsis (12.7%), hemorrhage (11.4%), cardiomyopathy (11%), thrombotic pulmonary embolism (9.2%), hypertensive disorders of pregnancy (7.4%), cerebrovascular accidents (6.6%), amniotic fluid embolus (AFE) (5.5%), anesthesia complications (0.2%), and unknown causes (6.1%)
- Drugs useful in the treatment of uterine atony in an asthmatic patient with severe preeclampsia include
A. Oxytocin (Pitocin) only
B. Ergonovine (Ergotrate) or methylergonovine (Methergine) only
C. 15-Methyl prostaglandin F2α (PGF2α) (Carboprost, Hemabate) only
D. All of the above are safe and can be used alone or in combination with the others
(A)Uterine atony is a common cause of postpartum hemorrhage (2%-5% of all vaginal deliveries). Treatment consists of uterine massage, drugs, and, in some cases, tamponade balloon placement (e.g., Bakri with 300-500mL normal saline), uterine artery embolization, laparotomy with hemostatic sutures, or, in rare cases, hysterectomy. Drugs commonly used include oxytocin, ergot alkaloids (ergonovine, methylergonovine), prostaglandins (PGE2, PGF2α, 15-methyl PGF2α), and misoprostol. Oxytocin (Pitocin) is the first-line drug used for the treatment of uterine atony and may be used in patients with asthma or hypertensive disorders of pregnancy. If oxytocin is given as a large IV bolus, vasodilation and hypotension often result. Oxytocin is often given as 3 units over 30 seconds every 3 minutes for 3 doses or 30 units in 500mL of fluid over 2 hours or 10 units IM. The ergot alkaloids are associated with a high incidence of nausea and vomiting. They cause vasoconstriction, producing elevations in blood pressure, and are contraindicated in patients with hypertension (and in this case preeclampsia). The dose of Methergine is 0.2mg IM every 2 to 4 hours up to 5 doses. Ergot alkaloids have also been associated with bronchospasm (rarely) and may not be appropriate in asthmatic patients. Thus the ergot alkaloids are relatively contraindicated in patients with hypertension (such as preeclampsia), coronary artery disease, and asthma. The prostaglandin 15-methyl PGF2α (Carboprost, Hemabate) is the only prostaglandin currently approved for uterine atony in the United States and may cause significant bronchospasm in susceptible patients and is contraindicated in asthmatic patients. The dose of Hemabate is 0.25mg IM every 15 to 90 minutes up to 2mg. Other smooth muscle contraction-associated side effects of prostaglandin 15-methyl PGF2α include venoconstriction, as well as gastrointestinal (GI) muscle spasm (nausea, vomiting, and diarrhea). The prostaglandin E1 misoprostol (Cytotec) has been given (off label) for postpartum hemorrhage. Misoprostol can be given once rectally (800-1000mcg) or sublingually or orally (600-800mcg) and is used if oxytocin or ergot alkaloids are ineffective. In some cases, tranexamic acid 1000mg IV is given if blood loss is expected to be >500 to 1000mL over anticipated blood loss
- What is the P50 of fetal hemoglobin at term?
A. 12 mm Hg
B. 18 mm Hg
C. 24 mm Hg
D. 30 mm Hg
(B)Newborns have high hemoglobin levels around 15 to 20g/100mL. The term P50 denotes the blood oxygen tension (Pao2) that produces 50% saturation of erythrocyte hemoglobin. The P50 value of fetal hemoglobin is 18mm Hg versus the adult value of 27mm Hg. Thus fetal hemoglobin has a higher affinity for oxygen than maternal hemoglobin
- Side effects of terbutaline include all of the following EXCEPT
A. Hypertension
B. Hyperglycemia
C. Pulmonary edema
D. Hypokalemia
(A)Terbutaline is a β-adrenergic agonist with tocolytic properties and can be administered IV and subcutaneously, as well as orally. Side effects are similar to those of other β-adrenergic drugs and include tachycardia, hypotension, myocardial ischemia, pulmonary edema (0.3% incidence), hypoxemia (inhibition of hypoxic pulmonary vasoconstriction), hyperglycemia (30% incidence), metabolic (lactic) acidosis, hypokalemia (39% incidence and due to a shift of potassium from extracellular to intracellular space), anxiety, and nervousness. Electrocardiogram (ECG) changes with ST segment depression and T wave flattening or inversion may occur and typically resolve after stopping the β-adrenergic therapy. Whether these ECG changes reflect myocardial ischemia or hypokalemia is unclear
- Cardiac output increases dramatically during pregnancy and delivery. The cardiac output returns to nonpregnant values by how long postpartum?
A. 12 hours
B. 1 day
C. 2 weeks
D. 6 months
(C)The numerous changes that take place in the cardiovascular system during pregnancy provide for the needs of the fetus and prepare the mother for labor and delivery. During the first trimester of pregnancy, cardiac output increases by approximately 30% to 40%. At term, the cardiac output is increased 50% over nonpregnant values. This increase in cardiac output is due to an increase in stroke volume and an increase in heart rate. During labor, the cardiac output increases another 10% to 15% during the latent phase, 25% to 30% during the active phase, and 40% to 45% during the expulsive stage. Each uterine contraction increases the cardiac output by about 10% to 25%. The greatest increase in cardiac output occurs immediately after delivery of the newborn, when the cardiac output can increase to 75% above prelabor values. This final increase in cardiac output is attributed primarily to autotransfusion and increased venous return associated with uterine involution. Cardiac output falls to prelabor values within 2 days after delivery; however, it takes about 2 weeks for the cardiac output to decrease to nonpregnant values
- A 32-year-old parturient with a history of spinal fusion, severe asthma, and hypertension (blood pressure 180/110) is brought to the operating room wheezing. She needs an emergency cesarean section under general anesthesia for a prolapsed umbilical cord. Which of the following induction agents would be MOST appropriate for her induction?
A. Sevoflurane
B. Midazolam
C. Ketamine
D. Propofol
(D)Asthma occurs in about 4% to 8% of all pregnancies. Although sevoflurane is a good induction agent for asthmatic patients, a rapid-sequence IV induction with endotracheal intubation to secure the airway is preferred. Because midazolam has a slow onset of action, it is not recommended for a rapid-sequence induction. When inducing general anesthesia in an asthmatic patient, it is imperative to establish an adequate depth of anesthesia before placing an endotracheal tube. If the patient is “light,” then severe bronchospasm may occur. In patients with asthma, IV induction will work with ketamine or propofol. Ketamine is considered by many as the induction agent of choice due to its mild bronchodilator properties, but because propofol (also a good induction agent in asthmatic patients) does not stimulate the cardiovascular system as ketamine does, propofol would be preferred in this patient with hypertensive disorders of pregnancy. In patients with mild asthma who do not need the accessory muscles of respiration, regional anesthesia should be strongly considered if time permits because it would eliminate the need for endotracheal intubation. In addition, inhaled β2-adrenergic agonist (e.g., albuterol) and IV steroids may be beneficial
- Uterine blood flow at term pregnancy typically increases to about
A. 100 mL/min
B. 250 mL/min
C. 500 mL/min
D. 750 mL/min
(D)Uterine blood flow increases dramatically from 50 to 100mL/min before pregnancy to about 700 to 900mL/min at term (i.e., >1 unit of blood per minute). From 70% to 90% of the uterine blood flow at term goes to the intervillous spaces. Uterine blood flow is related to the perfusion pressure (uterine arterial pressure minus uterine venous pressure) divided by the uterine vascular resistance. Thus factors that decrease uterine blood flow include systemic hypotension, aortocaval compression, uterine contraction, and vasoconstriction
- Which one of the following statements is TRUE regarding human immunodeficiency virus (HIV) infected parturients?
A. Central neurologic blockade and epidural blood patches increase the chance of neurologic complications
B. Ninety percent of newborns of untreated HIV-seropositive mothers become infected in utero, during vaginal delivery, or with breastfeeding
C. The pharmacologic effects of benzodiazepines and narcotics are prolonged in patients taking protease inhibitors
D. The risk of seroconversion after percutaneous exposure to HIV-infected blood is about 5%
(C)Central neurologic blockade (i.e., epidural, spinal, or combined spinal-epidural), as well as epidural blood patches, appear to be safe for HIV-infected parturients. Vertical transmission from the mother to the newborn can occur in 15% to 40% when the mother is untreated. With antiretroviral therapy and elective cesarean delivery, the rate of transmission is reduced to about 1% to 2%. The risk of developing HIV after a needlestick injury with HIV-infected blood is 0.3%. (Risk of developing hepatitis B from a needlestick injury with hepatitis B infected blood is 30% and hepatitis C from a needlestick injury with hepatitic C infected blood is 2%-4%.) Patients taking protease inhibitors as part of their drug therapy have inhibition of cytochrome P-450, and both benzodiazepines, as well as narcotics, have prolonged effects
- Which of the following cardiovascular parameters is decreased at term?
A. Central venous pressure
B. Pulmonary capillary wedge pressure
C. Systemic vascular resistance
D. Left ventricular end-systolic volume
(C)There is no change in central venous pressure, pulmonary capillary wedge pressure, pulmonary artery diastolic pressure, or left ventricular end-systolic volume. Left ventricular end-diastolic volume is increased, as is stroke volume, ejection fraction, heart rate, and cardiac output. Systemic vascular resistance is decreased about 20%
- Which of the following signs and symptoms is NOT associated with amniotic fluid embolism (AFE)?
A. Chest pain
B. Bleeding (disseminated intravascular coagulation [DIC])
C. Pulmonary vasospasm with severe pulmonary hypertension and right heart failure
D. Left ventricular failure and pulmonary edema
(A)AFE is a very rare but serious complication of labor and delivery that results from the entrance of amniotic fluid and constituents of amniotic fluid into the maternal systemic circulation. About 10% of maternal deaths are caused by AFE, and two thirds of these deaths occur within 5 hours. Of those patients who survive the AFE, about 50% have significant neurologic dysfunction. For AFE to occur, the placental membranes must be ruptured, and abnormal open sinusoids at the uteroplacental site or lacerations of endocervical veins must exist. The classic triad is acute hypoxemia, hemodynamic collapse (i.e., severe hypotension), and coagulopathy without an obvious cause. More than 80% of these women develop cardiopulmonary arrest. Hemodynamic monitoring often shows a biphasic response; initially pulmonary vasospasm with severe pulmonary hypertension and right heart dysfunction is seen, followed by left ventricular failure and pulmonary edema. DIC occurs in about 66% of cases, and seizures occur about 50% of the time. Recently AFE is believed to be a bit different from a pure embolic event, because findings of anaphylaxis and septic shock also are involved. Bronchospasm, however, is rare (<15%) during an AFE, and chest pain is very rare (2% of patients)
- When is the fetus most susceptible to the effects of teratogenic agents?
A. 1 to 2 weeks of gestation
B. 3 to 8 weeks of gestation
C. 9 to 14 weeks of gestation
D. 15 to 20 weeks of gestation
(B)Organogenesis mainly occurs between the 15th and 56th days (3-8 weeks) of gestation in humans and is the time during which the fetus is most susceptible to teratogenic agents. Although all commonly used anesthetic drugs are teratogenic in some animal species, there is no conclusive evidence to implicate any currently used local anesthetics, IV induction agents, or volatile anesthetic agents in the causation of human congenital anomalies
- A 28-week estimated gestational age (EGA), 1000-g male infant is born to a 24-year-old mother who is addicted to heroin. The mother admits taking an extra “hit” of heroin before coming to the hospital because she was nervous. The infant’s respiratory depression would be best managed by
A. 0.1 mg/kg naloxone intramuscularly (IM) in the newborn’s thigh muscle
B. 0.1 mg/kg naloxone down the endotracheal tube
C. 0.4 mg naloxone IM to the mother during the second stage of labor
D. None of the above
(D)Opioid use during pregnancy has escalated dramatically in recent years and parallels the opioid epidemic observed in the general population. Opioid abuse during pregnancy is estimated to occur in about 5% of patients in the United States, most often with the nonprescription use of pain-relieving drugs such as oxycodone. Other opioids include morphine, heroin, methadone, meperidine, and fentanyl. The problems associated with abuse are many and include the drug effect itself and the effects of substances mixed with the narcotics (e.g., talc, cornstarch), as well as infection and malnutrition. Neonatal abstinence syndrome (NAS) or drug withdrawal syndrome has increased from 1.5 cases per 1000 hospital births in 1999 to 6 cases per 1000 hospital births in 2013. NAS is manifested by central nervous system (CNS), GI symptoms of irritability, high-pitched cry, and poor sleep and sucking reflexes that lead to poor feeding. After delivery, respiratory depression as manifested by a low respiratory rate is treated with controlled ventilation but not with naloxone. Naloxone can precipitate an acute withdrawal reaction and should not be administered to patients with chronic narcotic use (mother or newborn). The dose of naloxone to treat narcotic-induced respiratory depression in the nonaddicted newborn was 0.1mg/kg, but more recent data suggest that it may worsen the neurologic damage caused by asphyxia. Animal studies have also raised the question of complications such as pulmonary edema and cardiac arrest, as well as seizures, and current recommendations are to avoid naloxone use in the newborn. Current recommendations are to assist ventilation until the narcotic effects wear off and not to use naloxone (this includes nonaddicted mothers who have just received narcotics during labor)